METHYLSULFONYL SUBSTITUTED MURRAYANINE-CHALCONE COMPOUND AS ANTI-BREAST CANCER AGENTS: SCREENING AGAINST MCF-7 CELL LINE

Debarshi Kar Mahapatra, Ruchi S Shivhare

Abstract


Introduction: In the normal course, the activity of murrayanine is very minimal and the most attractive way to improve the anti-proliferative activity involves semi-synthesis. Previously, hybrids of murrayanine (tert-butyl containing, thiazole-linked, uracil-fused) have been screened by our research group which showed promising enhancement (several-folds) in the activity. Objective: In the present research, (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl)phenyl)prop-2-en-1-one was screened against breast cancer cell line MCF-7 employing the SRB assay and studied to establish its IC50 value in comparison with the standard drug. The synergistic anti-cancer activity of the combination of carbazole scaffold (eminent anti-neoplatic effect), murrayanine moiety (fair anti-proliferative agent), chalcone scaffold (prominent anti-cancer activity), and methylsulfonyl component in the para position of the ring-B (high anti-tumor potential) was explored considerably. Results: The anti-breast cancer potential of the substituted murrayanine-chalcone was found to be quite incredible as indicated by the IC50 value of 37.16 μM in comparison with the positive control capecitabine (IC50 value of 6.49 μM). Conclusion: The methylsulfonyl group substituted murrayanine-chalcone scaffold produced noteworthy anti-proliferative activity against breast cancer cell line MCF-7. The present interesting study will inspire the researchers and will positively provide directions towards the future rational development of potential low-molecular-weight ligands with profound anti-cancer activity.

Full Text:

PDF

References


Mahapatra DK, Bharti SK. Drug Design. New Delhi: Tara Publications Private Limited, 2016.

Vardanyan R, Hruby V. Synthesis of essential drugs. 1st Ed. Amsterdam: Elsevier Science; 2006.

Shivhare RS, Mahapatra DK, Nair RR, Deshmukh SN. Schiff’s base derivatives of murrayanine demonstrated enhanced anti-oxidant activity than its parent moiety. (2016) Indian J Pharm Edu Res 50(4): 9-15.

Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem 2018;2(2):47-51.

Mahapatra DK, Dadure KM, Shivhare RS. MCF-7 cell line screening of some uracil containing murrayanine based (thio)-semicarbazide hybrids. Innovat Int J Med Pharm Sci 2018; 3(5): 14-16.

Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors. Int J Pharm Sci Drug Res 2017; 9(3): 139-144.

Mahapatra DK, Shivhare RS, Kumar P. Tert-butyl Group bearing Murrayanine-chalcone Produced Noteworthy Anti-proliferative Activity against Breast Cancer Cell Line. J Adv Res BioChem Pharmacol 2018;1(3&4):4-6.

Mahapatra DK, Asati V, Bharti SK. Chalcones and their role in management of diabetes mellitus: Structural and pharmacological perspectives. Eur J Med Chem 2015;92:839-865.

Mahapatra DK, Bharti SK. Therapeutic Potential of chalcones as cardiovascular agents. Life Sci 2016;148:154-172.

Mahapatra DK, Bharti SK, Asati V. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives. Curr Top Med Chem 2017;17(28):3146-69.

Mahapatra DK, Bharti SK, Asati V. Anti-cancer Chalcones: Structural and molecular targets perspectives. Eur J Med Chem 2015; 98: 69-114.

Mahapatra DK, Bharti SK, Asati V. Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives. Eur J Med Chem 2015;101:496-524.

Gibson NW, Erickson LC, Kohn KW. DNA damage and differential cytotoxicity produced in human cells by 2-chloroethyl (methylsulfonyl) methanesulfonate (NSC 338947), a new DNA-chloroethylating agent. Cancer Res 1985;45(4):1674-9.

Brent TP, Lestrud SO, Smith DG, Remack JS. Formation of DNA interstrand cross-links by the novel chloroethylating agent 2-chloroethyl (methylsulfonyl) methanesulfonate: suppression by O6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts. Cancer Res 1987;47(13):3384-7.

Gibson NW, Hartley JA, Strong JM, Kohn KW. 2-Chloroethyl (methylsulfonyl) methanesulfonate (NSC-338947), a more selective DNA alkylating agent than the chloroethylnitrosoureas. Cancer Res 1986;46(2):553-7.

Finch RA, Shyam K, Penketh PG, Sartorelli AC. 1, 2-Bis (methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Cancer Res 2001;61(7):3033-8.

Polli JW, Olson KL, Chism JP, John-Williams LS, Yeager RL, Woodard SM, Otto V, Castellino S, Demby VE. An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl) oxy] phenyl}-6-[5-({[2-(methylsulfonyl) ethyl] amino} methyl)-2-furyl]-4-quinazolinamine; GW572016). Drug Metab Disposit 2009;37(2):439-42.

Ismail B, Ghezali L, Gueye R, Limami Y, Pouget C, Leger DY, Martin F, Beneytout JL, Duroux JL, Diab-Assaf M, Fagnere C. Novel methylsulfonyl chalcones as potential antiproliferative drugs for human prostate cancer: Involvement of the intrinsic pathway of apoptosis. Int J Oncol 2013;43(4):1160-8.

Hardy JR, Harvey VJ, Paxton JW, Evans P, Smith S, Grove W, Grillo-Lopez AJ, Baguley BC. Phase I Trial of the Amsacrine Analogue 9-({2-Methoxy-4-[(methylsulfonyl) amino]-phenyl}] amino)-N, 5-dimethyl-4-acridinecarboxamide (CI-921). Cancer Res 1988;48(22):6593-6.

Mahapatra DK, Shivhare RS. Anti-microbial Perspective of a Chalcone, (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl)phenyl)prop-2-en-1-one: Fabrication of a Hybrid by Unification of a Natural Product with a Synthetic Component. Int J Agr Life Sci 2018;4(2):236-240.

Padole CD, Amdare MD, Jogdand KR, Kathane LL, Kuhite NG, Mahapatra DK. Discovery of 4-methyl-2-oxo-2H-chromen-7-yl-2-benzamidoacetate as Anti-proliferative Agent. Int J Ayur Pharm Chem 2018; 8(1): 62-68.


Refbacks



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.